Q2 2024 Holdings
Filed 2024-08-14 | 48 holdings | $369.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM)Put | COM PAR $.01 | 457669307 | $91.3M | 1,362,700 | 24.7% |
| Labcorp Holdings Inc(LH) | COM SHS | 504922105 | $50.0M | 245,902 | 13.5% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $23.4M | 111,078 | 6.3% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $16.9M | 155,304 | 4.6% |
| Smith & Nephew PLC(SNN) | SPDN ADR NEW | 83175M205 | $14.4M | 579,619 | 3.9% |
| Pacira Biosciences Inc(PCRX)Put | COM | 695127100 | $13.0M | 455,500 | 3.5% |
| Organon & Co(OGN) | COMMON STOCK | 68622V106 | $12.6M | 608,096 | 3.4% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $12.0M | 312,000 | 3.3% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $10.2M | 225,165 | 2.8% |
| Vaxart Inc(VXRT) | COM NEW | 92243A200 | $9.9M | 14,764,991 | 2.7% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $9.6M | 600,294 | 2.6% |
| Abbott Laboratories(ABT) | COM | 002824100 | $9.3M | 89,500 | 2.5% |
| The Cigna Group(CI) | COM | 125523100 | $8.9M | 26,786 | 2.4% |
| Kenvue Inc(KVUE) | COM | 49177J102 | $8.8M | 485,000 | 2.4% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $8.7M | 192,000 | 2.3% |
| Erasca Inc(ERAS) | COM | 29479A108 | $6.8M | 2,874,536 | 1.8% |
| Biodesix Inc | COM | 09075X108 | $6.7M | 4,347,855 | 1.8% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $4.6M | 510,267 | 1.3% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $4.6M | 71,740 | 1.2% |
| Bausch Plus Lomb Corp(BLCO) | COMMON SHARES | 071705107 | $4.4M | 302,710 | 1.2% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $4.4M | 2,708,408 | 1.2% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $4.2M | 491,128 | 1.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $3.2M | 125,174 | 0.9% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $3.1M | 78,000 | 0.8% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $2.7M | 1,328,352 | 0.7% |
| Modular MED Inc(MODD) | COM NEW | 60785L207 | $2.4M | 1,539,352 | 0.7% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.4M | 175,301 | 0.6% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $2.3M | 177,004 | 0.6% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $2.1M | 163,363 | 0.6% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $2.0M | 668,115 | 0.5% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $1.9M | 217,864 | 0.5% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $1.8M | 778,924 | 0.5% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $1.8M | 293,417 | 0.5% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $1.5M | 159,626 | 0.4% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $1.4M | 2,499,800 | 0.4% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $1.2M | 320,394 | 0.3% |
| Aprea Therapeutics Inc(APRE) | COM NEW | 03836J201 | $1.1M | 276,603 | 0.3% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $960.8K | 315,000 | 0.3% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $891.1K | 71,458 | 0.2% |
| Foghorn Therapeutics Inc.(FHTX) | COM | 344174107 | $699.6K | 121,672 | 0.2% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $627.2K | 162,058 | 0.2% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $397.6K | 133,412 | 0.1% |
| Nyxoah S A(NYXH) | SHS | B6S7WD106 | $354.3K | 50,839 | 0.1% |
| Nextcure Inc | COM | 65343E108 | $206.7K | 130,000 | 0.1% |
| Aslan Pharmaceuticals LTD | SPON ADS NEW | 04522R200 | $76.2K | 254,150 | 0.0% |
| Humacyte Inc | *W EXP 08/27/202 | 44486Q111 | $70.5K | 49,998 | 0.0% |
| Rocket Pharmaceuticals Inc | *W EXP 09/02/202 | 77313F114 | $28.9K | 400,000 | 0.0% |
| Caremax Inc | *W EXP 06/08/202 | 14171W111 | $200 | 12,808 | 0.0% |